ClinicalTrials.Veeva

Menu

Effect of Photobiomodulation on the Treatment of Soft Tissue Traumatic Injuries

U

University of Nove de Julho

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Soft Tissue Injuries

Treatments

Other: Sham Photobiomodulation
Radiation: Photobiomodulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04361773
TraumaSoftTissue

Details and patient eligibility

About

Soft tissue injuries are directly related to the energy of the trauma and its repair is the main factor for bone healing and the recovery of the function of the affected limb. Photobiomodulation (PBM) is indicated as an adjuvant treatment to accelerate wound healing, however, there is still a lack of evidence regarding its effect on traumatic soft tissue injuries. This project aims to evaluate the effects of the application of PBM in the resolution of complex soft tissue injuries of traumatic origin associated with tibial fractures. 84 adult individuals, aged between 18 and 60 years, hospitalized with tibial fractures awaiting resolution of soft tissue injuries will be included to undergo definitive surgery. The subjects will be randomized in two groups: PBM (treated with a device with 144 LED emitting diodes at wavelengths of 420, 660 and 850nm, 3J per point for 10 minutes) and Sham (simulation of the LED application, with a device with characteristics identical to that of the PBM group, for the same period of time). Subjects will be treated daily until release for surgery. The primary outcome will be the assessment of the wound healing process using the BATES-JENSEN scale. Secondary outcomes will be: pain intensity; consumption of analgesic drugs; serum evolution of inflammatory markers C-reactive protein and creatine kinase, measurement of the lesion area, time needed for release for definitive surgery, presence of infection, and the cost-effectiveness of PBM. The evaluations will be carried out before the beginning of the intervention and daily until the participant is considered ready for surgery (which will be considered the end of the experimental period). Data will be analyzed statistically considering a significance level of 5%.

Enrollment

84 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult individuals of both sexes, aged between 18 and 60 years;
  • Interned in the Orthopedics and Infirmary Emergency Room of the Surgical Clinic of Conjunto Hospitalar do Mandaqui;
  • Victims of high-energy trauma in the lower limbs with sufficient soft tissue injury to make primary closure unfeasible or definitive treatment of injuries in the initial care associated with tibial fracture.

Exclusion criteria

  • Diagnosis of chronic systemic diseases (renal failure, diabetes mellitus, hypertension, peripheral vascular insufficiency);
  • Allergy to cefazolin and gentamicin;
  • Uncontrollable active bleeding;
  • Occlusive arteriopathies;
  • Compartmental syndrome;
  • Necrosis in the area of neurovascular injury with sensory deficit at the injury site;
  • History of previous surgeries on the affected limb;
  • Local or systemic changes that contraindicate surgical intervention or hinder the postoperative period;
  • Smoking;
  • Photo sensitivity history;
  • Neurological and psychiatric disorders;
  • Use of anti-inflammatory drugs in the last 15 days prior to the trauma;
  • Pregnant women.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

84 participants in 2 patient groups

Photobiomodulation group
Active Comparator group
Description:
In this group, PBM will be applied daily using LED devices until the lesion presents healthy granulation tissue, absence of necrosis and purulent secretion and, therefore, is suitable for primary closure, closure by flap or graft or for healing by second intention. At this point, the protocol will be finalized.
Treatment:
Radiation: Photobiomodulation
Sham group
Sham Comparator group
Description:
Sham group participants will receive the application of the disconnected device, for the same period. The characteristic sound of the device will be activated by means of recording.
Treatment:
Other: Sham Photobiomodulation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems